Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: January 5, 2012
Last updated: September 21, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 29, 2014